aluates Reports

$ 0.0

Automative

Global Ranibizumab Market Research Report 2026

Published Date: 2026-04-02

Report Code: QYRE-Auto-3C9418

Global Ranibizumab Market Insights and Forecast to 2028

BUY CHAPTERS

Global Ranibizumab Market Research Report 2026

Code: QYRE-Auto-3C9418

Report

2026-04-02

Pages:98

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Coherus

Biogen

Ranibizumab Market Size

The global Ranibizumab market was valued at US$ 2555 million in 2025 and is anticipated to reach US$ 1245 million by 2032, at a CAGR of -9.9% from 2026 to 2032.

Ranibizumab Market

Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab.

The ranibizumab market is primarily driven by the increasing prevalence of eye diseases such as age-related macular degeneration (AMD), diabetic retinopathy, and macular edema. As the global population ages and diabetes rates rise, the demand for effective treatments like ranibizumab continues to grow. Ranibizumab, an anti-VEGF (vascular endothelial growth factor) therapy, has proven highly effective in reducing vision loss and improving patient outcomes. Additionally, advancements in drug delivery methods, along with expanding healthcare access in emerging markets, are supporting the growth of the ranibizumab market.

One of the key challenges in the ranibizumab market is the high cost of the drug, which can limit patient access, particularly in developing countries or among uninsured populations. While biosimilar versions are being developed, affordability remains a concern. Additionally, there is growing competition from alternative therapies and biosimilars that offer similar efficacy at a lower price. Patient adherence to treatment regimens, which often require frequent intravitreal injections, can also be a challenge, as some patients may find the process uncomfortable or inconvenient.

Global core ranibizumab manufacturers include Roche and Novartis etc. The Top 2 companies hold a share about 98%. North America is the largest market, with a share about 51%, followed by Europe and Asia Pacific with the share about 28% and 20%.

This report delivers a comprehensive overview of the global Ranibizumab market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Ranibizumab. The Ranibizumab market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Ranibizumab market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Ranibizumab manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Ranibizumab Market Report

Report Metric	Details
Report Name	Ranibizumab Market
Accounted market size in 2025	US$ 2555 million
Forecasted market size in 2032	US$ 1245 million
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Glass Vial Prefilled Syringe
Segment by Application	Wet AMD Complications of Diabetes RVO Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Coherus, Biogen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Ranibizumab companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

What is the Ranibizumab Market size in 2032?

Ans: The Ranibizumab Market size in 2032 will be US$ 1245 million.

What is the market share of major companies in Ranibizumab Market?

Ans: The Top 2 companies hold a share about 98%.

What is the Ranibizumab Market share by region?

Ans: North America is the largest market, with a share about 51%, followed by Europe and Asia Pacific with the share about 28% and 20%.

Who are the main players in the Ranibizumab Market report?

Ans: The main players in the Ranibizumab Market are Roche, Coherus, Biogen

What are the Application segmentation covered in the Ranibizumab Market report?

Ans: The Applications covered in the Ranibizumab Market report are Wet AMD, Complications of Diabetes, RVO, Others

What are the Type segmentation covered in the Ranibizumab Market report?

Ans: The Types covered in the Ranibizumab Market report are Glass Vial, Prefilled Syringe

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Ranibizumab Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Glass Vial

1.2.3 Prefilled Syringe

1.3 Market by Application

1.3.1 Global Ranibizumab Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Wet AMD

1.3.3 Complications of Diabetes

1.3.4 RVO

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Ranibizumab Market Perspective (2021–2032)

2.2 Global Ranibizumab Growth Trends by Region

2.2.1 Global Ranibizumab Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Ranibizumab Historic Market Size by Region (2021–2026)

2.2.3 Ranibizumab Forecasted Market Size by Region (2027–2032)

2.3 Ranibizumab Market Dynamics

2.3.1 Ranibizumab Industry Trends

2.3.2 Ranibizumab Market Drivers

2.3.3 Ranibizumab Market Challenges

2.3.4 Ranibizumab Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Ranibizumab Players by Revenue

3.1.1 Global Top Ranibizumab Players by Revenue (2021–2026)

3.1.2 Global Ranibizumab Revenue Market Share by Players (2021–2026)

3.2 Global Top Ranibizumab Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Ranibizumab Revenue

3.4 Global Ranibizumab Market Concentration Ratio

3.4.1 Global Ranibizumab Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Ranibizumab Revenue in 2025

3.5 Global Key Players of Ranibizumab Head Offices and Areas Served

3.6 Global Key Players of Ranibizumab, Products and Applications

3.7 Global Key Players of Ranibizumab, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Ranibizumab Breakdown Data by Type

4.1 Global Ranibizumab Historic Market Size by Type (2021–2026)

4.2 Global Ranibizumab Forecasted Market Size by Type (2027–2032)

5 Ranibizumab Breakdown Data by Application

5.1 Global Ranibizumab Historic Market Size by Application (2021–2026)

5.2 Global Ranibizumab Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Ranibizumab Market Size (2021–2032)

6.2 North America Ranibizumab Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Ranibizumab Market Size by Country (2021–2026)

6.4 North America Ranibizumab Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Ranibizumab Market Size (2021–2032)

7.2 Europe Ranibizumab Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Ranibizumab Market Size by Country (2021–2026)

7.4 Europe Ranibizumab Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Ranibizumab Market Size (2021–2032)

8.2 Asia-Pacific Ranibizumab Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Ranibizumab Market Size by Region (2021–2026)

8.4 Asia-Pacific Ranibizumab Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Ranibizumab Market Size (2021–2032)

9.2 Latin America Ranibizumab Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Ranibizumab Market Size by Country (2021–2026)

9.4 Latin America Ranibizumab Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Ranibizumab Market Size (2021–2032)

10.2 Middle East & Africa Ranibizumab Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Ranibizumab Market Size by Country (2021–2026)

10.4 Middle East & Africa Ranibizumab Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Ranibizumab Introduction

11.1.4 Roche Revenue in Ranibizumab Business (2021–2026)

11.1.5 Roche Recent Development

11.2 Coherus

11.2.1 Coherus Company Details

11.2.2 Coherus Business Overview

11.2.3 Coherus Ranibizumab Introduction

11.2.4 Coherus Revenue in Ranibizumab Business (2021–2026)

11.2.5 Coherus Recent Development

11.3 Biogen

11.3.1 Biogen Company Details

11.3.2 Biogen Business Overview

11.3.3 Biogen Ranibizumab Introduction

11.3.4 Biogen Revenue in Ranibizumab Business (2021–2026)

11.3.5 Biogen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Coherus

Biogen

List of Tables

Table 1. Global Ranibizumab Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Glass Vial

Table 3. Key Players of Prefilled Syringe

Table 4. Global Ranibizumab Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Ranibizumab Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Ranibizumab Market Size by Region (US$ Million), 2021–2026

Table 7. Global Ranibizumab Market Share by Region (2021–2026)

Table 8. Global Ranibizumab Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Ranibizumab Market Share by Region (2027–2032)

Table 10. Ranibizumab Market Trends

Table 11. Ranibizumab Market Drivers

Table 12. Ranibizumab Market Challenges

Table 13. Ranibizumab Market Restraints

Table 14. Global Ranibizumab Revenue by Players (US$ Million), 2021–2026

Table 15. Global Ranibizumab Market Share by Players (2021–2026)

Table 16. Global Top Ranibizumab Players by Tier (Tier 1, Tier 2, and Tier 3), based on Ranibizumab Revenue, 2025

Table 17. Ranking of Global Top Ranibizumab Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Ranibizumab Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Ranibizumab, Headquarters and Area Served

Table 20. Global Key Players of Ranibizumab, Products and Applications

Table 21. Global Key Players of Ranibizumab, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Ranibizumab Market Size by Type (US$ Million), 2021–2026

Table 24. Global Ranibizumab Revenue Market Share by Type (2021–2026)

Table 25. Global Ranibizumab Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Ranibizumab Revenue Market Share by Type (2027–2032)

Table 27. Global Ranibizumab Market Size by Application (US$ Million), 2021–2026

Table 28. Global Ranibizumab Revenue Market Share by Application (2021–2026)

Table 29. Global Ranibizumab Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Ranibizumab Revenue Market Share by Application (2027–2032)

Table 31. North America Ranibizumab Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Ranibizumab Market Size by Country (US$ Million), 2021–2026

Table 33. North America Ranibizumab Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Ranibizumab Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Ranibizumab Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Ranibizumab Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Ranibizumab Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Ranibizumab Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Ranibizumab Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Ranibizumab Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Ranibizumab Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Ranibizumab Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Ranibizumab Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Ranibizumab Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Ranibizumab Market Size by Country (US$ Million), 2027–2032

Table 46. Roche Company Details

Table 47. Roche Business Overview

Table 48. Roche Ranibizumab Product

Table 49. Roche Revenue in Ranibizumab Business (US$ Million), 2021–2026

Table 50. Roche Recent Development

Table 51. Coherus Company Details

Table 52. Coherus Business Overview

Table 53. Coherus Ranibizumab Product

Table 54. Coherus Revenue in Ranibizumab Business (US$ Million), 2021–2026

Table 55. Coherus Recent Development

Table 56. Biogen Company Details

Table 57. Biogen Business Overview

Table 58. Biogen Ranibizumab Product

Table 59. Biogen Revenue in Ranibizumab Business (US$ Million), 2021–2026

Table 60. Biogen Recent Development

Table 61. Research Programs/Design for This Report

Table 62. Key Data Information from Secondary Sources

Table 63. Key Data Information from Primary Sources

Table 64. Authors List of This Report

List of Figures

Figure 1. Ranibizumab Picture

Figure 2. Global Ranibizumab Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Ranibizumab Market Share by Type: 2025 vs 2032

Figure 4. Glass Vial Features

Figure 5. Prefilled Syringe Features

Figure 6. Global Ranibizumab Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Ranibizumab Market Share by Application: 2025 vs 2032

Figure 8. Wet AMD Case Studies

Figure 9. Complications of Diabetes Case Studies

Figure 10. RVO Case Studies

Figure 11. Others Case Studies

Figure 12. Ranibizumab Report Years Considered

Figure 13. Global Ranibizumab Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Ranibizumab Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Ranibizumab Market Share by Region: 2025 vs 2032

Figure 16. Global Ranibizumab Market Share by Players in 2025

Figure 17. Global Ranibizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Ranibizumab Revenue in 2025

Figure 19. North America Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Ranibizumab Market Share by Country (2021–2032)

Figure 21. United States Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Ranibizumab Market Share by Country (2021–2032)

Figure 25. Germany Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Ranibizumab Market Share by Region (2021–2032)

Figure 33. China Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Ranibizumab Market Share by Country (2021–2032)

Figure 41. Mexico Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Ranibizumab Market Share by Country (2021–2032)

Figure 45. Israel Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Ranibizumab Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Roche Revenue Growth Rate in Ranibizumab Business (2021–2026)

Figure 49. Coherus Revenue Growth Rate in Ranibizumab Business (2021–2026)

Figure 50. Biogen Revenue Growth Rate in Ranibizumab Business (2021–2026)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lucentis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lucentis Ranibizumab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ranibizumab Drugs and Biosimilars Market Research Report 2024

Global Bevacizumab Market Insights Forecast to 2030

Global Anti VEGF Drugs for the Treatment of Wet AMD Market Research Report 2024

Bevacizumab Monoclonal Antibody Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ranibizumab Injection Market Research Report 2024

Global Avastin Bevacizumab Biosimilars Market Research Report 2024

Global Broluzumab Biosimilars Market Research Report 2025

Global Monoclonal Antibody Anti VEGF Ophthalmic Drugs Market Research Report 2024

Global Rituximab Biosimilars Market Research Report 2025

Global Monoclonal Antibody VEGF Inhibitors Market Research Report 2024

Global Bevacizumab Generics Market Research Report 2024

Bevacizumab Biosimilar Market

Global Monoclonal antibodies mAbs Biosimilars Market Research Report 2024

Global Berzosertib VE 822 Market Research Report 2024

Global Antibody Drugs Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions